SentiAR is a digital health company that offers a holographic AR platform for intraprocedural clinical use.
SentiAR has raised $8.5M in total funding. The most recent round was Series B. The last funding was announced in April 2023.
SentiAR's investors include Cultivation Capital, National Institutes of Health, Arch Grants, BioGenerator, MedVenture Partners.
SentiAR is headquartered in St Louis, United States.
SentiAR is a digital health company that offers a holographic AR platform for intraprocedural clinical use.
SentiAR is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SentiAR — Funding & Investors." VCBacked, April 11, 2023, https://www.vcbacked.co/company/sentiar. Accessed July 19, 2026.
VCBacked. (2023). SentiAR — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sentiar
{{cite web |title=SentiAR — Funding & Investors |url=https://www.vcbacked.co/company/sentiar |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated